Egg and Sperm Donation: Medical Indications, Screening, and Legal Frameworks
Key Takeaways
Gamete donation is a regulated reproductive option in some countries when treatment with a person's own eggs or sperm is not possible or a serious inherited condition cannot be avoided by another suitable route. It is not available within Turkey's licensed IVF framework, which is limited to the gametes of the married couple receiving treatment.
Key evidence: ASRM Practice Committee Guidance on Gamete and Embryo Donation (2024) Turkish Ministry of Health Regulation on Assisted Reproductive Treatment Centers ASRM Ethics Committee Opinion on Interests and Rights in Gamete Donation
On this page
- Understanding Third-Party Reproduction
- Medical Indications for Gamete Donation
- Donor Screening and Safety Standards (ASRM/ESHRE)
- International Legal Variations vs. Turkish Regulation
- Counselling and Psychological Considerations
- FAQ
- Sources
Understanding Third-Party Reproduction
Third-party reproduction uses eggs, sperm, or embryos from a donor. In countries where it is permitted, it may be considered when treatment with a person’s own gametes is not possible, when a serious inherited condition cannot be avoided by another suitable route, or in other circumstances recognised by local clinical guidance.
Because a donor contributes genetic material, the decision is not only medical. Counselling may also cover family relationships, disclosure to a donor-conceived child, the limits of screening, and the law in the country where treatment would take place.
In Turkey, licensed IVF treatment does not include donor eggs, donor sperm, or donor embryos. Treatment planning must therefore begin with a clear review of what is medically appropriate and legally available in Turkey. Surrogacy is also outside the permitted framework.
Dr. Aksoy’s Approach
The finding that most changes my counselling is concrete evidence that the couple can produce a usable embryo with their own gametes. I do not interpret AMH or one semen analysis in isolation. Age, antral follicle count, previous mature oocytes and embryo development matter for women; viable sperm in the ejaculate or focal spermatogenesis at micro-TESE matter for men. I explain the realistic chance, time, cost, and emotional burden of another attempt without selling hope or closing the door because of a single result.
Medical Indications for Gamete Donation
Indications vary by patient, country, and professional guidance. The following examples are drawn mainly from US ASRM guidance and should not be read as universal eligibility rules (ASRM Practice Guidance, 2024):
1. Indications for Egg (Oocyte) Donation
- Premature ovarian insufficiency (POI): Loss of normal ovarian activity before age 40. Diagnosis is based on the clinical history and appropriate hormone testing; AMH alone does not diagnose POI.
- Loss of ovarian function after surgery or treatment: Bilateral oophorectomy or severe follicular damage after gonadotoxic chemotherapy or pelvic radiotherapy.
- Age-related decline in oocyte availability or competence: Considered only after an individual review of prognosis and remaining options.
- Risk of transmitting a serious genetic condition: A high risk of an X-linked or autosomal dominant disorder when preimplantation genetic testing (PGT-M) is not feasible or is declined.
- Repeated poor oocyte or embryo development: This may prompt a wider review, but previous IVF failure alone does not establish that donor oocytes are the only option.
2. Indications for Sperm Donation
- Azoospermia or another severe sperm disorder: Donor sperm may be discussed when usable sperm cannot be obtained or when further surgical retrieval is not appropriate. Micro-TESE is an individual decision, not a universal prerequisite.
- Severe Hereditary Genetic Conditions: Paternal carrier status for severe chromosomal or genetic abnormalities where PGT is unfeasible.
- Selected infectious-disease situations: Decisions depend on the infection, current specialist guidance, risk-reduction options, and informed consent. No screening or processing method removes every transmission risk.
Donor Screening and Safety Standards (ASRM/ESHRE)
Screening rules are set by the treatment country’s law and regulatory system. ASRM’s 2024 guidance describes US requirements and recommendations; it explicitly notes that they may not transfer unchanged to other countries.
| Screening Domain | Required Assessments | Clinical Objective |
|---|---|---|
| Infectious-disease screening | Tests required by the local regulator; US guidance includes HIV, hepatitis B and C, syphilis, chlamydia and gonorrhoea, with some tests depending on donor type | Reduces, but cannot eliminate, transmission risk |
| Genetic assessment | Personal and family history plus carrier screening appropriate to the donor and recipient; broader panels may be considered | Identifies reproductive risks and supports informed matching and counselling |
| Medical and family history | A detailed history, often covering three generations where available | Identifies findings that may need genetic review; it is not a guarantee of future health |
| Psychoeducational counselling | Discussion of consent, future contact, disclosure, and the implications of donation | Helps donors and recipients make an informed decision |
International Legal Variations vs. Turkish Regulation
The legal and ethical status of gamete donation varies widely across countries (Turkish Ministry of Health Regulation):
| Country / Jurisdiction | Egg Donation | Sperm Donation | Legal Framework |
|---|---|---|---|
| Turkey | Prohibited | Prohibited | Strictly restricted to biological gametes of legally married couples |
| United Kingdom | Permitted | Permitted | Regulated by HFEA; non-anonymous (identity-release at age 18) |
| Spain | Permitted | Permitted | Donation is confidential under national law, with limited statutory exceptions |
| Greece | Permitted | Permitted | The donor may choose among identity arrangements allowed under current Greek law |
| United States | Permitted | Permitted | Rules vary by state and programme; directed and nonidentified arrangements are used |
Regulatory Framework in Turkey
Under the Turkish regulatory framework for assisted reproduction, licensed treatment is based on the gametes of the married couple receiving treatment. Donor eggs, donor sperm, and donor embryos are not available within that framework. Patients should obtain jurisdiction-specific legal advice before arranging treatment or transporting reproductive tissue across borders.
Counselling and Psychological Considerations
Third-party reproduction involves profound emotional, ethical, and familial considerations (ASRM Ethics Committee Opinion, 2019):
- Grief and Acceptance: Processing the loss of a genetic connection to the child before embarking on treatment.
- Disclosure and transparency: Professional guidance encourages prospective parents to consider early, age-appropriate disclosure, while recognising that family circumstances and legal frameworks differ.
- Anonymity vs. Open-Identity: Understanding whether the treatment jurisdiction uses anonymous donor protocols or identity-release registries when the child reaches adulthood.
FAQ
Is egg or sperm donation legal in Turkey?
No. Gamete donation, embryo donation, and surrogacy are completely prohibited under Turkish law. All IVF clinics in Turkey are legally licensed to treat married couples using exclusively their own eggs and sperm.
Can an international patient bring donor eggs or donor sperm to Turkey for IVF?
No. Importing third-party gametes or embryos into Turkey for clinical treatment is prohibited by Turkish healthcare regulations.
Does egg donation guarantee a 100% pregnancy rate?
No. Outcomes vary with the donor, recipient, embryo, laboratory, treatment protocol, and the way a clinic defines its denominator. A clinic’s pregnancy rate per transfer is not the same as the chance of a live birth per treatment started.
What alternatives exist for women with low AMH who want treatment in Turkey?
Low AMH does not by itself show whether pregnancy is possible or identify one best protocol. Age, antral follicle count, previous response, diagnosis, and the patient’s priorities all matter. Natural-cycle, mild-stimulation, or other approaches may be discussed, but none can guarantee more or better-quality eggs.
Related Reading
- Male Infertility and IVF: Diagnosis and Treatment Options
- Egg Freezing Guide: Timing, Protocols, and Oocyte Numbers
- Understanding the Three Main Types of IVF: Natural, Mild, and Conventional
- Micro-TESE for Non-Obstructive Azoospermia
Sources
- Practice Committee of the American Society for Reproductive Medicine. Gamete and embryo donation guidance. Fertility and Sterility. 2024;122:799–813.
- Ministry of Health of the Republic of Turkey. Regulation on Assisted Reproductive Treatment Applications and Centers. Official Gazette.
- Ethics Committee of the American Society for Reproductive Medicine. Interests, obligations, and rights in gamete and embryo donation: an Ethics Committee opinion. Fertility and Sterility. 2019;111(4):664–670.
- ESHRE Working Group on Reproductive Donation. Good practice recommendations for information provision for those involved in reproductive donation. Human Reproduction Open. 2022;2022(1):hoac001. doi:10.1093/hropen/hoac001.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.